Surgery Partners, Inc. (SGRY) stock
SGRYNasdaqServices-General Medical & Surgical Hospitals, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 5/308% above fair value
$26.95+0.37 (+1.39%)
Close on Nov 13, 2026Market cap $3.53BP/E –Yield –
Surgery Partners total assets
Total assets on the balance sheet at the end of each period.
Surgery Partners's total assets was $7.05B at Sep 30, 2026. For fiscal 2025 it was $8.12B, up 2.9% from the year before. Over ten years it grew 14.5% a year on average. The highest annual figure on record is $8.12B in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.12B | +2.9% |
| FY2024 | Dec 31, 2024 | $7.89B | +14.7% |
| FY2023 | Dec 31, 2023 | $6.88B | +2.9% |
| FY2022 | Dec 31, 2022 | $6.68B | +9.2% |
| FY2021 | Dec 31, 2021 | $6.12B | +13.0% |
| FY2020 | Dec 31, 2020 | $5.41B | +7.9% |
| FY2019 | Dec 31, 2019 | $5.02B | +7.3% |
| FY2018 | Dec 31, 2018 | $4.68B | +1.2% |
| FY2017 | Dec 31, 2017 | $4.62B | +100.6% |
| FY2016 | Dec 31, 2016 | $2.30B | +9.5% |
| FY2015 | Dec 31, 2015 | $2.10B | +13.2% |
| FY2014 | Dec 31, 2014 | $1.86B | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $7.05B | -11.3% |
| Q2 FY2026 | Jun 30, 2026 | $8.05B | +1.2% |
| Q1 FY2026 | Mar 31, 2026 | $8.04B | +1.2% |
| Q4 FY2025 | Dec 31, 2025 | $8.12B | +2.9% |
| Q3 FY2025 | Sep 30, 2025 | $7.95B | +5.5% |
| Q2 FY2025 | Jun 30, 2025 | $7.95B | +6.2% |
| Q1 FY2025 | Mar 31, 2025 | $7.95B | +14.0% |
| Q4 FY2024 | Dec 31, 2024 | $7.89B | +14.7% |
| Q3 FY2024 | Sep 30, 2024 | $7.53B | +11.1% |
| Q2 FY2024 | Jun 30, 2024 | $7.49B | +13.1% |
| Q1 FY2024 | Mar 31, 2024 | $6.98B | +5.0% |
| Q4 FY2023 | Dec 31, 2023 | $6.88B | +2.9% |
| Q3 FY2023 | Sep 30, 2023 | $6.78B | +3.7% |
| Q2 FY2023 | Jun 30, 2023 | $6.62B | +5.2% |
| Q1 FY2023 | Mar 31, 2023 | $6.64B | +5.6% |
| Q4 FY2022 | Dec 31, 2022 | $6.68B | +9.2% |
| Q3 FY2022 | Sep 30, 2022 | $6.54B | +16.1% |
| Q2 FY2022 | Jun 30, 2022 | $6.29B | +11.9% |
| Q1 FY2022 | Mar 31, 2022 | $6.29B | +11.5% |
| Q4 FY2021 | Dec 31, 2021 | $6.12B | +13.0% |
| Q3 FY2021 | Sep 30, 2021 | $5.63B | +6.0% |
| Q2 FY2021 | Jun 30, 2021 | $5.62B | +7.2% |
| Q1 FY2021 | Mar 31, 2021 | $5.64B | +10.8% |
| Q4 FY2020 | Dec 31, 2020 | $5.41B | +7.9% |
| Q3 FY2020 | Sep 30, 2020 | $5.31B | +8.0% |
| Q2 FY2020 | Jun 30, 2020 | $5.24B | +7.2% |
| Q1 FY2020 | Mar 31, 2020 | $5.09B | +4.3% |
| Q4 FY2019 | Dec 31, 2019 | $5.02B | +7.3% |
| Q3 FY2019 | Sep 30, 2019 | $4.92B | +7.9% |
| Q2 FY2019 | Jun 30, 2019 | $4.89B | +6.7% |
| Q1 FY2019 | Mar 31, 2019 | $4.88B | +6.2% |
| Q4 FY2018 | Dec 31, 2018 | $4.68B | +1.2% |
| Q3 FY2018 | Sep 30, 2018 | $4.56B | -0.9% |
| Q2 FY2018 | Jun 30, 2018 | $4.58B | +71.6% |
| Q1 FY2018 | Mar 31, 2018 | $4.59B | +100.7% |
| Q4 FY2017 | Dec 31, 2017 | $4.62B | +100.6% |
| Q3 FY2017 | Sep 30, 2017 | $4.60B | – |
| Q2 FY2017 | Jun 30, 2017 | $2.67B | – |
| Q1 FY2017 | Mar 31, 2017 | $2.29B | – |
| Q4 FY2016 | Dec 31, 2016 | $2.30B | – |
See a number that looks wrong?